Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$948.8K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 24 most recent Form 4 transactions.
| 2,437 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Jun 30 | EYPT | EyePoint Pharmaceuticals,… | SSELL◷ | 2,438 | $15.02 | $36.6K | -100.0% | Open the original filing on SEC.gov |
| Jun 30 | EYPT | EyePoint Pharmaceuticals,… | SSELL◷ | 2,437 | $15.00 | $36.6K | -50.0% | Open the original filing on SEC.gov |
| Jun 30 | EYPT | EyePoint Pharmaceuticals,… | MEXER◷ | 2,438 | $8.26 | $20.1K | +100.0% | Open the original filing on SEC.gov |
| Jun 30 | EYPT | EyePoint Pharmaceuticals,… | MEXER◷ | 2,437 | $8.26 | $20.1K | — | Open the original filing on SEC.gov |
| Apr 17 | EYPT | EyePoint Pharmaceuticals,… | MEXER◷◆ | 2,437 | — | — | — | Open the original filing on SEC.gov |
| Apr 17 | EYPT | EyePoint Pharmaceuticals,… | SSELL◷ | 2,437 | $15.00 | $36.6K | -100.0% | Open the original filing on SEC.gov |
| Apr 17 | EYPT | EyePoint Pharmaceuticals,… | MEXER◷ | 2,437 | $8.26 | $20.1K | — | Open the original filing on SEC.gov |
| Mar 4 | EYPT | EyePoint Pharmaceuticals,… | MEXER◷◆ | 2,438 | — | — | — | Open the original filing on SEC.gov |
| Mar 4 | EYPT | EyePoint Pharmaceuticals,… | SSELL◷ | 2,438 | $17.87 | $43.6K | -100.0% | Open the original filing on SEC.gov |
| Mar 4 | EYPT | EyePoint Pharmaceuticals,… | MEXER◷ | 2,438 | $8.26 | $20.1K | — | Open the original filing on SEC.gov |
| Feb 17 | EYPT | EyePoint Pharmaceuticals,… | MEXER◷◆ | 2,437 | — | — | — | Open the original filing on SEC.gov |
| Feb 17 | EYPT | EyePoint Pharmaceuticals,… | SSELL◷ | 2,437 | $15.00 | $36.6K | -100.0% | Open the original filing on SEC.gov |
| Feb 17 | EYPT | EyePoint Pharmaceuticals,… | MEXER◷ | 2,437 | $8.26 | $20.1K | — | Open the original filing on SEC.gov |
| Jan 5 | EYPT | EyePoint Pharmaceuticals,… | MEXER◷◆ | 29,250 | — | — | — | Open the original filing on SEC.gov |
| Jan 5 | EYPT | EyePoint Pharmaceuticals,… | SSELL◷ | 42,544 | $17.10 | $727.3K | -100.0% | Open the original filing on SEC.gov |
| Jan 5 | EYPT | EyePoint Pharmaceuticals,… | MEXER◷ | 29,250 | $8.26 | $241.6K | +220.0% | Open the original filing on SEC.gov |
| Jan 3 | EYPT | EyePoint Pharmaceuticals,… | MEXER◆ | 19,667 | — | — | — | Open the original filing on SEC.gov |
| Jan 3 | EYPT | EyePoint Pharmaceuticals,… | FTAX | 6,373 | $17.48 | $111.4K | -32.4% | Open the original filing on SEC.gov |
| Jan 3 | EYPT | EyePoint Pharmaceuticals,… | MEXER | 19,667 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | EYPT | EyePoint Pharmaceuticals,… | AGRANT◆ | 171,400 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | EYPT | EyePoint Pharmaceuticals,… | AGRANT◆ | 85,700 | — | — | — | Open the original filing on SEC.gov |
| Nov 11, 2025 | EYPT | EyePoint Pharmaceuticals,… | SSELL◷ | 2,722 | $11.61 | $31.6K | -100.0% | Open the original filing on SEC.gov |